Factor Viii Replacement

Factor VIII Replacement is a therapeutic intervention involving the administration of exogenous Factor VIII to correct deficient or impaired endogenous Factor VIII activity in individuals with hemophilia A or other Factor VIII-deficient states.

1.1K

Publications

59.9K

Citations

4.1K

Authors

1.3K

Institutions

Publications per year

2017–2026

184

Variants

Factor Viii Replacement Therapy

Authors

4.1K

  1. ES
    Elena Santagostino

    Fondazione IRCCS Ca' Granda Ospedale Maggiore Policlinico, Italy

    33 publications · 4.7K citations

    25

    h-index

  2. PM
    Pier Mannuccio Mannucci

    University of Milan, Italy

    30 publications · 2.8K citations

    23

    h-index

  3. JO
    Johannes Oldenburg

    University of Bonn, Germany

    30 publications · 2.7K citations

    23

    h-index

  4. GF
    Glenn F. Pierce

    Amgen (United States), United States

    24 publications · 4.2K citations

    22

    h-index

  5. JM
    Johnny Mahlangu

    University of the Witwatersrand, South Africa

    24 publications · 4.6K citations

    19

    h-index

1–5 of 4.1K

Venues

  1. Blood

    105 publications · 11K citations

    57

    h-index

  2. Haemophilia

    236 publications · 10.5K citations

    50

    h-index

  3. Journal of Thrombosis and Haemostasis

    JTH · 74 publications · 4.7K citations

    40

    h-index

  4. Thrombosis and Haemostasis

    65 publications · 3K citations

    29

    h-index

  5. PubMed

    Repository · 92 publications · 3.5K citations

    27

    h-index

1–5